Patent details

EP1570871 Title: Local vascular delivery of cladribine in combination with rapamycin to prevent restenosis following vascular injury

Basic Information

Publication number:
EP1570871
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP052509080
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Local vascular delivery of cladribine in combination with rapamycin to prevent restenosis following vascular injury
French Title of Invention:
Administration vasculaire locale de Cladribine en combinaison avec Rapamycine pour la prévention de resténose à la suite d'une lésion vasculaire
German Title of Invention:
Lokale, vaskuläre Verabreichung von Cladribin in Kombination mit Rapamycin zur Vorbeugung von Restenose nach Gefässverletzungen
SPC Number:

Dates

Filing date:
17/02/2005
Grant date:
09/09/2009
EP Publication Date:
09/09/2009
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/09/2005
EP B1 Publication Date:
09/09/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/02/2010
Expiration date:
17/02/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/02/2005
 
 

Name:
Cordis Corporation
Address:
14201 N.W. 60th Avenue, Miami Lakes, Florida 33014, United States (US)

Inventor

1

Name:
Falotico Robert
Address:
United States (US)

2

Name:
Parry Tom Jay
Address:
United States (US)

3

Name:
Zhao Jonathon Z.
Address:
United States (US)

Priority

Priority Number:
780596
Priority Date:
18/02/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61L 31/16;
Filing date Document type Number of pages